http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Cardiovascular Systems (CSII) Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
-
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
-
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
-
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
-
Cardiovascular Systems (CSII) Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
-
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
-
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
-
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
-
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
-
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
-
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
-
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device
-
Cardiovascular Systems, Inc. Announces First In-Human Experience With Peripheral Everolimus Drug-Coated Balloon
-
Cardiovascular Systems (CSII) Appoints Jeffery W. Chambers as CMO
-
Cardiovascular Systems, Inc. Appoints Jeffery W. Chambers, M.D., as Chief Medical Officer
-
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
-
Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
-
Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference
-
Cardiovascular Systems (CSII) and OrbusNeich Announce FDA PMA Approval of Scoreflex Scoring Balloon
-
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon
-
Cardiovascular Systems (CSII) Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
-
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
-
CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
-
Cardiovascular Systems (CSII) Announces Voluntary Recall of WIRION
-
Cardiovascular Systems, Inc. Initiates Voluntary Recall of WIRION® Embolic Protection System
-
Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results
-
Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon
-
Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 First-Quarter Earnings Conference Call Tuesday, November 9
-
Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross™ Peripheral Support Catheter
-
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
-
Cardiovascular Systems, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results
-
Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Fourth-Quarter Earnings Conference Call Wednesday, August 4
-
Cardiovascular Systems, Inc. to Participate at the Raymond James Human Health Innovations Conference
-
Cardiovascular Systems, Inc. Announces U.S. Commercial Launch of JADE Over-the-Wire Non-Compliant Peripheral Balloon Catheters
-
New Study Demonstrates Exceptional Performance With Cardiovascular Systems’ Diamondback 360® Coronary Orbital Atherectomy System (OAS) Dual Mode of Action
-
Cardiovascular Systems, Inc. Reports Fiscal 2021 Third-Quarter Financial Results
-
Journal of Medical Economics Article Demonstrates Economic Benefits of Cardiovascular Systems Orbital Atherectomy in the Treatment of Peripheral Artery Disease (PAD)
-
Cardiovascular Systems, Inc. to Participate at BofA Securities 2021 Health Care Conference
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Third-Quarter Earnings Conference Call Thursday, May 6
-
Cardiovascular Systems (CSII) Announces Investment and Acquisition Option Agreement With Telehealth Company, CarePICS, LLC
-
Cardiovascular Systems, Inc. Announces Investment and Acquisition Option Agreement With Telehealth Company, CarePICS, LLC
-
Cardiovascular Systems, Inc. to Participate at the 20th Annual Needham Healthcare Conference
-
Cardiovascular Systems (CSII) Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC
-
Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC
-
Cardiovascular Systems, Inc. Announces First Uses of WIRION® Embolic Protection System
-
Cardiovascular Systems, Inc. to Participate at Four Upcoming Investor Conferences
-
Beta Bionics Announces the Appointment of Martha Goldberg Aronson as Chair of Its Board of Directors
